17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
2 March 2020
The Medicines and Healthcare products Regulatory Agency (MHRA) is requesting that healthcare professionals report any suspected side effects or safety concerns with e-cigarettes and the e-liquids used for vaping to the Yellow Card Scheme.
5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.
31 January 2020
The review was commissioned by the Chief Executive of NHS England to assist its Board in the evaluation of responses to a consultation undertaken in summer 2019 relating to a new draft service specification for children’s cancers.
16 December 2019
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.
16 October 2019
Withdrawal and Medicines Alerts for Ranitidine Related Products Zantac®, used to treat conditions such as acid reflux in children, has been recalled by its manufacturer because of concerns that it may contain low levels of NDMA.
9 October 2019
In April this year, the Welsh Government published a report produced by Royal College of Obstetricians and Gynaecologists and the Royal College of Midwives, reviewing maternity services at Cwm Taf Health Board.
6 June 2019
Today, Leslie Hamilton and his working group have published their independent review into how the law on gross negligence manslaughter and culpable homicide are applied to medical practice. RCPCH President, Professor Russell Viner, responds.
29 April 2019
At the European Congress on Obesity, which is being held in Glasgow this week, research will be presented about the associations between childhood body size and the risk of renal cancer. Dr Max Davie, RCPCH Officer for Health Improvement, responds.
9 April 2019
Boys aged 12-13 in Northern Ireland are to be offered a vaccine to protect them against Human Papillomavirus (HPV) related cancers, the Department of Health has announced. RCPCH responds.